Buddhist Catholic Contemplative Evangelical General Christian Hindu Jewish Latter-day Saint Muslim New Visions Progressive Christian

Beliefs

Topics

Columnists

Resource Library

Research Tools

Video

Podcasts

Thought Readers

Faith In Media Tracker

Newsletters

Ad-Free & Subscriber Log-In Subscription Support

Follow Patheos

Catholic News

Home

Home
Catholic
Religion News
Women stunned at FDA’s failure to remove Essure from market

Women stunned at FDA’s failure to remove Essure from market

Last updated on: March 3, 2016 at 10:02 am by CNA Daily News

Women stunned at FDA’s failure to remove Essure from market 2016-03-03T10:02:00+00:00 CNA Daily News

LOGO Patheos Explore the world's faith through different perspectives on religion and spirituality! Patheos has the views of the prevalent religions and spiritualities of the world.

Washington D.C., Mar 3, 2016 / 03:02 am (CNA/EWTN News).- The FDA announced Monday that it will add its strictest warning to the label of Essure, a sterilization device in the form of flexible metal coils inserted into the fallopian tubes.

But the decision still comes as a blow to thousands of “E-sisters” – women who have experienced the often debilitating side effects of the device and who have been pushing to get Essure completely removed from the market.

“We are outraged that it appears as if the FDA is going to leave Essure on the market while it implements a draft guidance and labeling recommendations within a black boxed warning as well as ordering new clinical studies,” the group said in a statement on their website.

“Clearly Essure's PMA (pre-market approval) should be revoked and the device should be pulled from the market. These studies could take several years, and leaving the device on the market will only put more women's lives at risk.”

A so-called “black box” warning has been recommended for the device, which is “designed to call attention to serious or life-threatening risks” of the device including “persistent pain, perforation of the uterus or fallopian tubes from device migration, abnormal bleeding and allergy or hypersensitivity reactions,” according to an FDA statement.

Touted as the only form on non-surgical permanent birth control, implanted Essure coils are supposed to stay in the fallopian tubes, where they create a chronic infection causing scar tissue to form, effectively closing the tubes and rendering the woman sterile. The device was first manufactured by the group Conceptus and pre-approved by the FDA before hitting the markets in 2002. In June 2014, Conceptus was bought by Bayer, which has continued to manufacture and distribute Essure.

In addition to the “black box” warning, the FDA asked Bayer to include a “patient decision checklist” in Essure's packaging, “to ensure women receive and understand information regarding the benefits and risks of this type of device,” and is accepting the public’s input on the device for 60 days.

The FDA has also ordered Bayer to conduct a three-year clinical study in which they will follow 2,000 women who have been implanted with Essure, and compare them to women who’ve had different sterilization procedures. The FDA expects Bayer to submit a study protocol within 30 days and the company is required by law to begin the study within 15 months, CNN reports. If Bayer does not comply, the FDA can declare the device misbranded.

The Facebook page “Essure Problems” is over 27,000 members strong (up from 14,000 just last year) and serves as a place where the “E-sisters” women band together for support and protest the device. They tell their stories to women considering the device and provide the names and locations of doctors who won’t dismiss women’s Essure complaints.

“We have provided the FDA with enough relevant data to prove that Essure is unsafe,” the group said in a statement following the FDA’s latest announcement.

“Take the device off the market and revoke PMA. Do not continue to allow more women to be harmed. Unless the FDA takes those steps, we intend to push for Congress to force the hand of the FDA. We will not be stopped or silenced.”

Rep. Mike Fitzpatrick, a Republican from Pennsylvania, introduced the “E-free” act to Congress in November, a bill calling for the device to be pulled from the market. He said the latest move from the FDA is unacceptable in the face of all the women who have already suffered because of Essure.

“It's unbelievable that it took the FDA since September to make just two recommendations with no enforcement measures and ask the manufacturer to perform another study while leaving Essure on the market,” he said in a statement following the announcement.

“It's been done. The evidence is all there: Tens of thousands of injured women and hundreds of fetal deaths.”

On the “Essure Problems” Facebook page, women log complaints about chronic pain, allergic reactions, perforated organs, migrating coils, and fetal disfigurement caused by the device.

Dr. William Maisel, deputy director for science and chief scientist at the FDA's Center for Devices and Radiological Health, said in a news briefing Monday that the agency has received 631 reports of women becoming pregnant while using the product, and 294 reports of pregnancy losses.

“Like all forms of birth control, Essure is not perfect and women may become pregnant despite use of the device. The lack of an Essure confirmation test is the most common factor contributing to unintended pregnancies in women with Essure,” Maisel said.

The FDA has received about 10,000 complaints of adverse effects since the device’s approval in 2002. Instructions for how to file a complaint about Essure can be found on the Essure Problems website.

For 60 days, patients and doctors can submit their feedback to the FDA on the device, which will be taken into consideration before the addition of the new warning labels.

Previous Post

March 3, 2016

Pa. bishop urges prayers for victims after major sex abuse report

Next Post

March 3, 2016 This 95-year-old priest walked three miles while hearing confessions

Browse Our Archives

Select a Category Americas Asia - Pacific Europe Middle East - Africa Uncategorized US Vatican

Select a Month November 2017 October 2017 September 2017 August 2017 July 2017 June 2017 May 2017 April 2017 March 2017 February 2017 January 2017 December 2016 November 2016 October 2016 September 2016 August 2016 July 2016 June 2016 May 2016 April 2016 March 2016 February 2016 January 2016 December 2015 November 2015 October 2015 September 2015 August 2015 July 2015 June 2015 May 2015 April 2015 March 2015 February 2015 January 2015 December 2014 November 2014 October 2014 September 2014 August 2014 July 2014 June 2014 May 2014 April 2014 March 2014 February 2014 January 2014 December 2013 November 2013 October 2013 September 2013 August 2013 July 2013 June 2013 May 2013 April 2013 March 2013 February 2013 January 2013 December 2012 November 2012 October 2012 September 2012 August 2012 July 2012 June 2012 May 2012

TAKE THE

Religious Wisdom Quiz

Who was Rebekah's father?

Select your answer to see how you score.

Abraham Bethuel Laban Terah